Biomea Fusion (BMEA) Revenue & Revenue Breakdown
Biomea Fusion Revenue Highlights
00
Biomea Fusion Revenue by Period
Biomea Fusion Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Biomea Fusion generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Biomea Fusion Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $1.22M | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $6.14M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Biomea Fusion generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Biomea Fusion Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CAMP | CAMP4 Therapeutics | $186.23M | $795.00K |
| STRO | Sutro Biopharma | $62.04M | $9.69M |
| CBUS | Cibus | $4.26M | $933.00K |
| ADVM | Adverum Bio | $1.00M | - |
| GUTS | Fractyl Health | $120.00K | - |
| ALXO | ALX Oncology | - | - |
| RPTX | Repare Therapeutics | - | - |
| UNCY | Unicycive Therapeutics | - | - |
| BMEA | Biomea Fusion | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| IMUX | Immunic | - | - |